OCUP: Ocuphire Pharma, Inc. Company Short-Term Debt

This chart illustrates that the market value of Ocuphire Pharma, Inc. (OCUP) is fixed at 0.00. The business focuses on creating advanced eye drops that restore visual focus during age-related changes. The development of new molecules is accelerated through the implementation of AI and robotic screening. High returns are secured by FDA patents and the complexity of clinical trials, which create a significant barrier to entry for competitors.

Short-term debts represent the aggregate of all credit obligations with a maturity of up to one year, measuring a company's ability to maintain current liquidity. Analyzing financial debts with a maturity of up to one year allows for an assessment of capital shortage risks, which is critical for Ocuphire Pharma, Inc. (OCUP) when financing the sustainable synthesis of drugs and implementing zero-waste laboratory technologies.